Insiders · YARW

Iain Stuart

Chief Scientific Officer at VYNE Therapeutics Inc. (YARW)

Iain Stuart has filed 28 insider reports with the SEC since February 2021, as chief Scientific Officer at VYNE Therapeutics Inc. (YARW). The latest filing, on July 24, 2026, reports shares withheld for taxes or exercise price at VYNE Therapeutics Inc. (YARW).

Filings
28
Companies
1
Bought on market
None
Sold on market
None

Companies where Iain Stuart is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
VYNE Therapeutics Inc. logo
YARW
VYNE Therapeutics Inc.
Chief Scientific Officer95,944$14.23Jul 24, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Iain Stuart with

Other insiders at the same companies

Questions about Iain Stuart

What is Iain Stuart's role at VYNE Therapeutics Inc.?
Iain Stuart reports to the SEC as chief Scientific Officer at VYNE Therapeutics Inc. (YARW), according to the latest filing on July 24, 2026.
How many shares does Iain Stuart own?
After the latest filing that states it, Iain Stuart directly owned 95,944 shares of VYNE Therapeutics Inc. (YARW). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Iain Stuart bought or sold stock recently?
No open-market purchases or sales by Iain Stuart are on file. The filings report shares withheld for taxes or exercise price and grant or award.
How do I get alerts when Iain Stuart files?
Follow Iain Stuart on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Iain Stuart (SEC CIK 0001727756). Totals count each trade once, skipping amendments whose original is on file, from Feb 24, 2021 on. View on SEC EDGAR · Get this as JSON